Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XELOX-A in Metastatic Colorectal Cancer
NCT00416494Phase 2Completed
- Sponsor
- Herbert Hurwitz
- Start
- Sep 2003
- Primary completion
- Jan 2008
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by Herbert Hurwitz. Started Sep 2003; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00416494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00416494.